AAAAAA
Results:
1-9
|
Results: 9
Authors:
Markert, JM
Fuller, CM
Gillespie, GY
Bubien, JK
McLean, LA
Hong, RL
Lee, K
Gullans, SR
Mapstone, TB
Benos, DJ
Citation: Jm. Markert et al., Differential gene expression profiling in human brain tumors, PHYSIOL GEN, 5(1), 2001, pp. 21-33
Authors:
Berdiev, BK
Mapstone, TB
Markert, JM
Gillespie, GY
Lockhart, J
Fuller, CM
Benos, DJ
Citation: Bk. Berdiev et al., pH alterations "reset" Ca2+ sensitivity of brain Na+ channel 2, a degenerin/epithelial Na+ ion channel, in planar lipid bilayers, J BIOL CHEM, 276(42), 2001, pp. 38755-38761
Authors:
Markert, JM
Gillespie, GY
Weichselbaum, RR
Roizman, B
Whitley, RJ
Citation: Jm. Markert et al., Genetically engineered HSV in the treatment of glioma: a review, REV MED VIR, 10(1), 2000, pp. 17-30
Authors:
Markert, JM
Medlock, MD
Rabkin, SD
Gillespie, GY
Todo, T
Hunter, WD
Palmer, CA
Feigenbaum, F
Tornatore, C
Tufaro, F
Martuza, RL
Citation: Jm. Markert et al., Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial, GENE THER, 7(10), 2000, pp. 867-874
Authors:
Markert, JM
Citation: Jm. Markert, Glioma immunology and immunotherapy - Comment, NEUROSURGER, 46(4), 2000, pp. 791-792
Authors:
Markert, JM
Citation: Jm. Markert, Induction of apoptosis in glioma cells by recombinant human Fas ligand - Comment, NEUROSURGER, 46(2), 2000, pp. 438-439
Authors:
Parker, JN
Gillespie, GY
Love, CE
Randall, S
Whitley, RJ
Markert, JM
Citation: Jn. Parker et al., Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors, P NAS US, 97(5), 2000, pp. 2208-2213
Authors:
Bradley, JD
Kataoka, Y
Advani, S
Chung, SM
Arani, RB
Gillespie, GY
Whitley, RJ
Markert, JM
Roizman, B
Weichselbaum, RR
Citation: Jd. Bradley et al., Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus, CLIN CANC R, 5(6), 1999, pp. 1517-1522
Authors:
Advani, SJ
Chung, SM
Yan, SY
Gillespie, GY
Markert, JM
Whitley, RJ
Roizman, B
Weichselbaum, RR
Citation: Sj. Advani et al., Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors, CANCER RES, 59(9), 1999, pp. 2055-2058
Risultati:
1-9
|